Topic

All

25
Apr
2018

What Can You Do With Genomics and AI? Alice Zhang on The Long Run

Today’s guest on The Long Run podcast is Alice Zhang. Let’s start with some basic background. Zhang studied systems biology at Princeton, graduated with honors, enrolled in an MD/PHD program at UCLA/Caltech, stayed there five years, quit, moved to Silicon Valley, and co-founded a company dedicated to using her knowledge for neurodegenerative drug discovery. She has been named among the...
Read More
11
Apr
2018

The Immune Sequencing Frontier: Harlan and Chad Robins on The Long Run

Today on The Long Run are a pair of guests — Harlan and Chad Robins. They are the brothers who co-founded Seattle-based Adaptive Biotechnologies almost a decade ago. Chad is the CEO, and Harlan is the head of innovation. Adaptive, for those unfamiliar, has a specialized focus on sequencing regions of B-cells and T-cells of the adaptive immune system where...
Read More
28
Mar
2018

Teaching and Mentoring the Next Generation: Vicki Sato on The Long Run Podcast

Today’s guest on The Long Run podcast is Vicki Sato. She’s one of the biotech industry’s pioneers. Sato started out as a classic academic scientist on the Harvard faculty. Beginning in the mid-1980s, and for about 20 years, the next phase of her career was as an executive at Biogen and Vertex Pharmaceuticals. Her fingerprints are all over a number...
Read More
26
Mar
2018

Mt. Everest: It’s Time

Six months of hard training is in the bank. Tomorrow morning, I will lug a pair of 120-liter gear bags to the airport and get on the plane for Kathmandu. Destination: Mt. Everest, 29,029 feet/8,848 meters. The summit of the highest mountain in the world. No matter what happens, three things are certain: I’ve given it everything I’ve got to prepare...
Read More
14
Mar
2018

From Rock DJ to Scientist to Entrepreneur: Michael Gilman on The Long Run Podcast

Today’s guest on The Long Run podcast is Michael Gilman. He’s the CEO of a pair of Boston-area biotech startups. One is Arrakis Therapeutics, a company attempting to make small molecule drugs against RNA targets. The other is Obsidian Therapeutics, a company seeking to take the next step in CAR-T immunotherapy, by carefully controlling dosing to avoid some of the...
Read More
12
Mar
2018

Photo Gallery: The Boston Cancer Summit

What a whirlwind last week was! The Seattle and Boston Cancer Summits were an East-West combo punch on behalf of the Everest Climb to Fight Cancer fundraising campaign for Fred Hutch. These events did the job: Bringing together leading thinkers and doers on both coasts, they both drew sellout, highly engaged crowds. The fundraising tally now stands at $326,000!! The...
Read More
12
Mar
2018

Photo Gallery: The Seattle Cancer Summit

What a whirlwind last week was! The Seattle and Boston Cancer Summits were an East-West combo punch on behalf of the Everest Climb to Fight Cancer fundraising campaign for Fred Hutch. These events did the job: Bringing together leading thinkers and doers on both coasts, they both drew sellout, highly engaged crowds. The fundraising tally now stands at $326,000!! The...
Read More
1 2 3 22